CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Reproduction, Fertility and Development   
Reproduction, Fertility and Development
  Vertebrate Reproductive Science & Technology
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Board
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Research Fronts
Sample Issue
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
Referee Guidelines
Review Article
Annual Referee Index
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates

blue arrow e-Alerts
blank image
Subscribe to our email Early Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter youtube

red arrow Connect with SRB
blank image
facebook TwitterIcon

Affiliated Societies

RFD is the official journal of the International Embryo Transfer Society and the Society for Reproductive Biology.



Article << Previous     |     Next >>   Contents Vol 22(1)

176 PREGNANCY AND PREGNANCY LOSS RATES OF ACYCLIC RECIPIENT MARES TREATED WITH TWO DIFFERENT LONG-ACTING PROGESTERONE CONCENTRATIONS

G. M. Greco A, J. A. Dell’aqua Jr A and M. A. Alvarenga A

UNESP-São Paulo State University, Botucatu, Brazil
   

Abstract
Export Citation
Print
  


Abstract

Long-acting progesterone compounds containing concentrations of 150 mg mL-1 (P4LA150) have been routinely used in Brazil, especially at the beginning and end of the breeding season when the percentage of recipient mares showing normal estrous cycles is low compared to donors (Greco GM et al. 2008 Proceedings 7th International Symposium on Equine Embryo Transfer, 59-60). However, recipients treated with P4LA150 must receive weekly administrations until pregnancies achieve 100 days. The present study aimed to evaluate pregnancy and pregnancy loss rates from acyclic mares treated at 7-day intervals with P4LA150 and 14-day intervals with a long-acting progesterone formulation containing 300 mg mL-1 (P4LA300). Acyclic Campolina breed mares (n = 80) ranging from 4 to 13 years old showing considerable endometrial edema 2 days after estradiol benzoate injection (5 mg, i.m.) were split in 2 groups. Group 1 mares (n = 40) received 10 mL of P4LA150 (1500 mg) i.m. every 7 days, whereas Group 2 mares (n = 40) were treated with 10 mL of P4LA300 (3000 mg) i.m. every 14 days. Steroid hormone formulations were produced in our research laboratory, at São Paulo State University, Botucatu, Brazil. Embryos 7 to 8 days of age were transferred into the uteri of recipients between 4 and 7 days after the first progesterone administration. Following a positive pregnancy diagnosis at 14 to 15 days, mares were examined at Days 50 and 100, when progesterone treatment was discontinued. These evaluations were conducted in order to determine pregnancy loss rates during both periods. Results were analyzed through the chi-square test and significance was set at P < 0.05. Pregnancy rates and pregnancy loss rates at Day 50 from mares treated with P4LA150 (Group 1) and P4LA300 (Group 2) did not differ. Pregnancy rates were 60.0% (24/40) and 75.0% (30/40) at Day 50 for mares treated with P4LA150 (Group 1) and P4LA300 (Group 2), respectively (P > 0.10). Pregnancy loss rates at Day 50 were 8.3% (2/24) and 10.0% (3/30) for mares treated with P4LA150 and P4LA300, respectively (P > 0.10). Pregnancy losses were not identified at Day 100. Based on the results from the present study, we concluded that acyclic recipient mares treated with P4LA150 or P4LA300 are able to obtain satisfactory pregnancy rates with low pregnancy losses. Moreover, the use of 3000 mg of long-acting progesterone every 14 days reduces overall progesterone administrations, minimizes stress in horse handling, and makes the choice for acyclic recipient mares more appealing in commercial embryo transfer programs.


Authors would like to thank FAPESP for financial support.

Reproduction, Fertility and Development 22(5305) 246–246   http://dx.doi.org/10.1071/RDv22n1Ab176
Published online: 08 December 2009




 
Top  Email this page
 
   


Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2014